Citation
Paniz, Zarghami Dastjerdi
(2024)
Immunogenicity and efficacy of infectious bursal disease virus (IBDV) vaccines against the Malaysian variant IBDV in broiler chickens.
Masters thesis, Universiti Putra Malaysia.
Abstract
Infectious bursal disease (IBD) (Gumboro disease) is a viral disease in young
chickens that causes immunosuppression. It is caused by the infectious bursal
disease virus (IBDV), a highly resistant non-enveloped RNA virus. Effective
disease control and prevention strategies focus on farm biosecurity and
vaccination. However, the emergence of novel variant IBDV (nvarIBDV) has
challenged vaccine efficacy. An improved version of the herpesvirus of turkey
(HVT) vector vaccine, HVT+IBD+ND, has been developed recently. However,
the efficacy of IBDV vaccines has not been evaluated against the emerging
Malaysian variant of IBDV in commercial broiler chickens. This study
evaluated the immunogenicity and efficacy of live attenuated and viral vector
vaccines against variant IBDV in chickens.
In the immunogenicity study, ELISA method was used to detect antibody titers.
The HVT+IBD group had a higher mean antibody titer compared to the HVT+IBD+ND group, as detected by the VP2 IBDV-specific ELISA (p<0.05) in
the broiler chickens at 28 days old. Both vaccinated groups showed low bursal
lesion scores. As expected, antibody titers were detectable by the VP2 IBDVspecific
ELISA but not with the whole IBDV-specific ELISA. Real-time qPCR
showed a significantly higher HVT load in the HVT+IBD group (p<0.05). Upon
comparison with the IBD-BLEN, it seems that the IBD-BLEN vaccine
generates a high mean antibody titer (1623.00 ± 2031.13 and 4775.00 ±
3418.77) as detected by whole IBDV and VP2 IBDV-specific ELISA,
respectively, however, it is associated with a high bursal lesion score of 3.0 at
28-day-old chickens.
The efficacy of the HVT-based vaccine against the nvarIBDV strain
UPM1432/2019 was evaluated. The HVT+IBD vaccine and HVT+IBD+ND
vaccinated birds have seroconversion rates against IBD of 97% and 32.5%,
respectively. However, both groups had bursal lesions following challenged
with nvarIBDV. The HVT+IBD group had a higher mean antibody titer (7168 ±
3753.26), and less bursal damage at day 7 and 14 post-challenge compared
to HVT+IBD+ND (1209.1 ± 1252.88) (p<0.05), indicating the HVT+IBD
vaccine offers partial protection against nvarIBDV challenge. In addition, the
HVT+IBD group had a statistically higher normalized HVT value in the bursa
and spleen than the HVT+IBD+ND group (p<0.05). Although the HVT loads
were higher for HVT+IBD (p<0.05), variant IBDV loads were similar between
groups post-challenge (p > 0.05), indicating the vaccines could not induce
virus clearance.
The immunosuppression study showed variant IBDV challenge could inhibit
the antibody response after Newcastle disease (ND) vaccination in broiler
chickens with a significant reduction at day 14 post-challenge (1493.0 ± 746.1)
(p < 0.05) but not at day 7 (p > 0.05). In conclusion, the current HVT-based
vaccines against IBD cannot provide complete protection against the
Malaysian variant IBDV infection in commercial broiler chickens. In addition,
infection with variant IBDV can suppress the production of antibodies following
ND vaccination. Findings from this study recommend implementing new
strategies, including the use of variant IBD vaccine in controlling variant IBDV
and its immunosuppression effect in broiler chickens.
Download File
Additional Metadata
Item Type: |
Thesis
(Masters)
|
Subject: |
Infectious bursal disease virus - Vaccination |
Subject: |
Chickens - Diseases - Immunological aspects |
Subject: |
Viral diseases in poultry - Prevention |
Call Number: |
IB 2024 2 |
Chairman Supervisor: |
Professor Abdul Rahman bin Omar, PhD |
Divisions: |
Institute of Bioscience |
Keywords: |
Infectious Bursal Disease Virus, Gumboro disease, Broiler
chicken, Vector Vaccine, Live attenuated vaccine |
Depositing User: |
Ms. Rohana Alias
|
Date Deposited: |
04 Aug 2025 02:09 |
Last Modified: |
04 Aug 2025 02:09 |
URI: |
http://psasir.upm.edu.my/id/eprint/118144 |
Statistic Details: |
View Download Statistic |
Actions (login required)
 |
View Item |